Adam Karon - Mar 3, 2025 Form 4 Insider Report for AKAMAI TECHNOLOGIES INC (AKAM)

Signature
/s/ Thomas M. Lair, as power of attorney
Stock symbol
AKAM
Transactions as of
Mar 3, 2025
Transactions value $
-$517,632
Form type
4
Date filed
3/5/2025, 09:04 PM
Previous filing
Feb 25, 2025
Next filing
Mar 6, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKAM Common Stock Sale -$518K -6.43K -31.11% $80.49 14.2K Mar 4, 2025 Direct F1, F2
holding AKAM Common Stock 71 Mar 3, 2025 By 401(k) Plan F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKAM Performance Restricted Stock Units Award $0 +15.7K $0.00 15.7K Mar 3, 2025 Common Stock 15.7K $0.00 Direct F4, F5
transaction AKAM TSR Restricted Stock Units Award $0 +23.6K $0.00 23.6K Mar 3, 2025 Common Stock 23.6K $0.00 Direct F6, F7
transaction AKAM Restricted Stock Units Award $0 +39.3K $0.00 39.3K Mar 3, 2025 Common Stock 39.3K $0.00 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale was made pursuant to a Rule 10b5-1 Plan adopted by Mr. Karon on December 2, 2024.
F2 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $79.98 to $80.845, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 As of March 4, 2025.
F4 Each performance restricted stock unit ("PRSU") represents the right to receive one share of Akamai common stock upon vesting.
F5 Vesting of such PRSUs is dependent on Akamai's achievement of a specified financial performance targets for each of 2025, 2026 and 2027. To the extent such targets are met, the PRSUs will vest on the date the company's financial results for 2027 are certified. Amount reported is target issuable. Mr. Karon has elected to defer the receipt of 85% of such awards on the vesting date.
F6 Each TSR Restricted Stock Unit ("TSR RSU") represents the right to receive one share of Akamai common stock upon vesting.
F7 Vesting of such TSR RSUs is dependent on the relative cumulative total shareholder return of Akamai's common stock as compared to the S&P 500 Index for 2025, 2026 and 2027. To the extent the company's total shareholder return exceeds specified target percentile rankings within such index, the TSR RSUs will vest in full on the date the company's financial results for 2027 are certified. Amount reported is target issuable. Mr. Karon has elected to defer the receipt of 85% of such awards on the vesting date.
F8 Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting.
F9 RSUs vest over three years in equal installments on the first, second and third anniversaries of the grant date.